Medical lab test
Ended Awarded Last action
- Contract number
- W90VN622F5042
- Awardee
-
Seoul Clinical Laboratories UEI E961H2AE4AN5
- Awarding agency
-
RCO Osan 411th CSB
Expeditionary Contracting Command, Department of Defense
- Obligated
- $4,351
Award facts
- Contract value 3% obligated
-
- $4,351.42 Current, with exercised options
- $150,000.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Funding agency
- Pacific Air Forces Air Force, Department of Defense
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 2 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- South Korea
Award details come from SAM.gov/FPDS.
About this award
This is a federal contract award to Seoul Clinical Laboratories, a for-profit research institute located in South Korea, by the Pacific Air Forces agency of the U.S. Department of Defense. The $150,000.00 Blanket Purchase Agreement (BPA) Call contract is for the provision of medical laboratory testing and diagnostic services, including COVID-19, general blood work, and pathology testing, to support U.S. military healthcare operations in South Korea. The contract has a period of performance through February 28, 2026 and is a firm-fixed-price award without any set-aside designation.
Seoul Clinical Laboratories has extensive experience delivering a wide range of medical laboratory services to U.S. military treatment facilities and personnel stationed in South Korea. The company holds several significant indefinite delivery vehicles (IDVs) with the Department of Defense, including a $11.3 million single-award IDV with the Army Medical Command for COVID-19 testing and a $250,000 multiple-award BPA with the Air Force Pacific Air Forces for pathology testing services. These contract vehicles allow DoD agencies to efficiently procure Seoul Clinical Laboratories' services as needed to support healthcare requirements for U.S. forces in the region.
Quick answers
Who was awarded contract W90VN622F5042?
W90VN622F5042 was awarded to Seoul Clinical Laboratories by RCO Osan 411th CSB (Expeditionary Contracting Command) on May 1, 2022.
How much is contract W90VN622F5042 worth?
The government has obligated $4,351 on W90VN622F5042. Its potential value, with all options, is $150,000.
Which agency awarded contract W90VN622F5042?
RCO Osan 411th CSB (Expeditionary Contracting Command) awarded W90VN622F5042, with funding from Pacific Air Forces (Air Force).
Is contract W90VN622F5042 an order under another contract?
Yes. W90VN622F5042 is a BPA call under W90VN621A0006, a blanket purchase agreement.
Was contract W90VN622F5042 competed?
The extent of competition for W90VN622F5042 was competed under sap. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award